Kohjin Bio CoTSE:177A +0.23%17 Days Payable is 14.71 as of Mar. 2026, which is 25% below its 10-year median of 19.57. GuruFocus rates TSE:177A with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 701 Biotechnology companies, Kohjin Bio Co ranks worse than 92.01% on this metric.
The historical rank and industry rank for Kohjin Bio Co's Days Payable or its related term are showing as below:
TSE:177A'
s Days Payable Range Over the Past 10 Years
Min: 14.87 Med: 19.57 Max: 41.76
Current: 15.41
During the past 5 years, Kohjin Bio Co's highest Days Payable was 41.76. The lowest was 14.87. And the median was 19.57.
TSE:177A's Days Payable is ranked worse than 92.01% of 701
companies
in the Biotechnology industry
Industry Median: 112.84
vs TSE:177A: 15.41
Kohjin Bio Co's Days Payable
declined
from Mar. 2025 (19.93) to Mar. 2026 (14.71).
It may suggest that Kohjin Bio Coaccelerated paying its suppliers.
Kohjin Bio Co Days Payable Related Terms
Kohjin Bio Co Days Payable Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Kohjin Bio Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kohjin Bio Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kohjin Bio Co (TSE:177A) has a Days Payable of 14.71 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kohjin Bio Co and its competitors. This is 25% below median its historical median of 19.57. Over the past decade, Kohjin Bio Co's Days Payable has ranged from 14.87 to 41.76. According to the industry distribution chart, Kohjin Bio Co ranks #645 out of 701 companies in the Biotechnology industry, placing it in the top 92%.
Is Kohjin Bio Co's Days Payable too high?
Kohjin Bio Co's current Days Payable of 14.71 is 25% below median its 10-year median of 19.57. Over the past 10 years, this metric has ranged from a low of 14.87 to a high of 41.76. The Biotechnology industry median Days Payable is 112.84. Kohjin Bio Co's value of 14.71 is 87% below this industry median. Based on the distribution chart, Kohjin Bio Co ranks #645 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #645 out of 701 companies for Days Payable. This places Kohjin Bio Co in the lower half of its industry. The industry median Days Payable is 112.84. Kohjin Bio Co's value of 14.71 is 87% below this benchmark. Historically, Kohjin Bio Co's own Days Payable has ranged from 14.87 to 41.76 over the past decade. While the company's 10-year median is 19.57 vs. the industry median of 112.84, Kohjin Bio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current Days Payable of 14.71 is 87% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current Days Payable is 14.71, which is 25% below median its own 10-year median of 19.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Days Payable of 14.71. The current Days Payable is 14.71, which is 25% below median its 10-year median of 19.57 and 87% below the Biotechnology industry median of 112.84. Kohjin Bio Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Days Payable is 14.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
17GF Score
Get the complete analysis for TSE:177A
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 